Genetic testing company Natera (NASDAQ:NTRA). beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 34.7% year ...
Lowe's Companies shows solid fundamentals and growth in the Pro segment but faces headwinds. Read why LOW stock is rated Hold ...
Amcor gained 8% in volatility with revenue and EPS growth, a $10 target for 2026, 6%+ yield, and attractive valuation. Read ...
Dole’s third quarter was met with a positive market reaction, as the company exceeded Wall Street’s revenue expectations despite ongoing cost challenges in its Fresh Fruit segment. Management credited ...
Health Catalyst’s third quarter results were met with a positive market reaction as the company delivered revenue above Wall Street expectations despite flat year-over-year performance. Management ...
Organon's third quarter was marked by better-than-expected top-line and bottom-line results, which were well received by the ...
Enviri’s third quarter results saw a positive market reaction, despite a flat topline and a notable miss on adjusted ...